Please use this identifier to cite or link to this item: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13060
Title: Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study
Author: Yeung, D. T.
Shanmuganathan, N.
Reynolds, J.
Branford, S.
Walia, M.
Yong, A. S. M.
Shortt, J.
Chee, L.
Viiala, N.
Cunningham, I.
Ross, D. M.
D'Souza, A.
Wright, M.
Harrup, R.
Forsyth, C.
Filshie, R.
Lane, S.
Browett, P.
Grove, C.
Grigg, A. P.
Hughes, T. P.
Viiala, N.
Issue Date: 2024
Journal: Blood
Abstract:  Asciminib is a myristoyl site BCR
ISSN: 00064971 (ISSN)
Digital object identifier: 10.1182/blood.2024024657
URI: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13060
Appears in Collections:Liverpool Hospital

Files in This Item:
There are no files associated with this item.


Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing